Dr. Conrad Christian Weihl, MD

Dr. Weihl practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Weihl's NPI, 1437175759, was assigned on July 14, 2006. Dr. Weihl graduated from University of Chicago, Pritzker School of Medicine in 2002. Dr. Weihl holds Missouri license 2004020029.

Dr. Weihl's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Weihl also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Weihl's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Weihl to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Weihl practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Weihl's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Weihl is licensed in Missouri.

CMS data shows 149 Medicare services from Dr. Weihl across 4 procedure codes in 2024, for 79 Medicare patients. Medicare paid $10,977 for them. Every service was in an office.

CMS counts 79 Medicare patients who saw Dr. Weihl in 2024. The largest group is 65 to 74, with 38 patients. 72% of them have high blood pressure, and 70% have high cholesterol. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Weihl's median patient age at 66, with 57% women.

In 2024, Dr. Weihl wrote 180 Medicare Part D claims for 33 patients. 69% of them were for generic drugs. CMS names the drug for 131 of them, across 6 drugs with 11 or more claims each, at $760,632 in total drug cost. In 2023, CMS named 91 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Weihl for performance year 2024, reported as part of a group. Dr. Weihl accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Weihl as offering telehealth.

Dmand AI links 76 papers to Dr. Weihl, published from 2015 to 2025. 2022 was the busiest year, with 12. The most frequent topics are Muscle, Skeletal, Muscular Dystrophies, Limb-Girdle and Myositis, Inclusion Body. Dr. Weihl has published most often in Neuromuscul Disord. Dr. Weihl's most frequent co-authors are Tahseen Mozaffar, MD, Alan Pestronk, MD and Matthew Paul Wicklund, MD.

CMS Open Payments shows 67 general payments to Dr. Weihl from 8 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 81% of the total. Sarepta Therapeutics, Inc. paid the most, $64,721. It also lists 8 research payments totaling $17,815 from 2016 to 2025, naming 1 clinical trial.

Dr. Weihl graduated from University of Chicago, Pritzker School of Medicine in 2002.